< B C957491E48E86312E696E6464>

Similar documents
Microsoft Word - 14_LCMS_アクリルアミド

☆H23 13-農薬一斉分析(大垣).doc

JAJP


Agilent AA ICP ICP-MS ICP-MS AA 55B AA LCD AA PC PC 240 AA / / AA 240FS/280FS AA AA FS 240Z/280Z AA GFAA AA Duo 1 PC AA 2 280FS AA

Agilent 7900 ICP-MS 1 1 Ed McCurdy 2 1 Agilent Technologies, Japan 2 Agilent Technologies, UK


Ⅱ6.3界面活性剤

untitled

untitled

untitled

untitled

BAANs理論に基づく保健指導プログラム暫定版

(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..

2 TBARS



42 3 u = (37) MeV/c 2 (3.4) [1] u amu m p m n [1] m H [2] m p = (4) MeV/c 2 = (13) u m n = (4) MeV/c 2 =

1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

取扱説明書 [F-05E]

4章 困難な課題への挑戦 核酸結晶学

<4D F736F F D F90858C6E5F C B B B838B>

税関分析25 年の進歩

2 (FDA) 1 1 A D E K 1 LC UV 15 HPLC 3.5 UHPLC Agilent 12 Infinity LC Agilent 12 Infinity (G1311B) Agilent 12 Infinity (G13E) Agilent 12 Infinity (G131

36 th IChO : - 3 ( ) , G O O D L U C K final 1

g 51 52

平成26年度 化学物質分析法開発報告書

元素分析

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料)

IS(A3) 核データ表 ( 内部転換 オージェ電子 ) No.e1 By IsoShieldJP 番号 核種核種半減期エネルギー放出割合核種番号通番数値単位 (kev) (%) 核崩壊型 娘核種 MG H β-/ce K A

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH

% %

03J_sources.key

ICP-OES ICP-MS

PALL NEWS vol.126 November 2017

untitled

(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12

ŁaŠšfiÁ‘W“ƒDFflÅ

untitled


2_R_新技術説明会(佐々木)

エディロールカプセルインタビューフォーム

1.8.2 Page MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) / Candida glabrata (25) 0.25 / 0.5 Candida guilliermondii a) (2)

Microsoft Word - 00”ŒŁ\”ƒf.doc

CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO

X線分析の進歩36 別刷

untitled

温泉の化学 1

hv (%) (nm) 2

4 1 Ampère 4 2 Ampere 31


Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6

Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene



橡H141(成人モニタリング12年まとめ)表紙・目次・

外因性内分泌攪乱化学物質調査暫定マニュアル(水質、底質、水生生物)

RAA-05(201604)MRA対応製品ver6

ESL ()-methyl 3-{4-[2-hydroxy-3-(isopropylamino)pro poxy]phenyl} propanoate monohydrochloride H 3 C O O JAN( ) JAN( )esmolol hydrochloride r-inn( )esm

生体ナノテク第4回_穴なし

DCHP

Taro13-第2章まとめ(最終).PDF

untitled

取扱説明書 [F-12C]

untitled

1 WSV SIR m/z Analyte RT (Min) SIR m/z Cone voltage (V) Ascorbic Acid (C) Thiamine (B1) Nicotinic Acid (B3) Pyridoxal (


2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO

物理化学I-第12回(13).ppt


ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1

HOE901 A S S Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Gly

untitled

HPLC 1M KH 2 PO 4 ph ml Anthranilic acid: AnA 600 ml ml AnA 1.0 ml / min Anthranilic acid= PRESSURE 140 kgf / cm 2

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10


RN201602_cs5_0122.indd

untitled

コロイド化学と界面化学

untitled


BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

まえがき

1 Q A 82% 89% 88% 82% 88% 82%

1/120 別表第 1(6 8 及び10 関係 ) 放射性物質の種類が明らかで かつ 一種類である場合の放射線業務従事者の呼吸する空気中の放射性物質の濃度限度等 添付 第一欄第二欄第三欄第四欄第五欄第六欄 放射性物質の種類 吸入摂取した 経口摂取した 放射線業 周辺監視 周辺監視 場合の実効線 場合

untitled

平成26年度 化学物質分析法開発報告書

PowerPoint プレゼンテーション

<4D F736F F D C6E30385F A B B83932E444F43>

日本電子News vol.44, 2012

AS LMD Sampling Manual

low_ JAJP.qxd

食糧 その科学と技術 No.43( )

untitled

040202PC用.doc

10-7 cm/ 50cm 10-6 cm/ 2,4-D 2 ph

エクラー軟膏0.3%、エクラークリーム0.3%、エクラーローション0.3%_IF

 

SEC (SEC) SEC SEC SEC 2

Transcription:

10 DDS New York Academy Renal Biochemistry (Elsevier) Glutathione (John Wiley & Sons) Antioxidants in Therapy and Preventive Medicine (Plenum) The Liver: Biology and Pathophysiology (Raven Press) NO SSC

Cu Zn Se A C E 2

1) 1) 1) 2) 3) 4) 1) 1) 1) 2) 3) 4) 1) ( )5 120 10 30 60 120 ( ) CR-300 135 ( ) RE-3305 2009 RVA X C A 1) 32 p.65-83 1985. Cu CuCl2 P 8 Cu CuCl2 1.0 mg% 30 60 90 120 min Cu 30 min 1/2 Cu CuCl2 Cu Cu

AIN93G 20 g/g Wistar 24 52 60 20 26 1, 2) 3) 2) 1) 2) 3) F344/N 3 17 AIN-93G 10 7 2 AIN-93G 7 Student t 5 3 1 3 1 4 1 A/G GOT 2 GPT ALP -GTP T3 T4 p = 0.069

3 ICR 1 kg 2 mg AIN-93G 1 AIN93G 10 HPLC Ca 1) 1) 1) 1) 1) 2) 2) 1) 1) 2) -3 FP FP FPH CHOL CHOL BA in vitro ] <> FP FPH 5 Wistar AIN93 50 FP FPH CHOL0.5% 0.1% 6 4 CHOL BA <In vitro > FP FPH CHOL BA FP FPH CHOL CHOL CHOL CHOL BA In vitro FP FPH BA CHOL FP BA CHOL FPH FP BA FP FPH CHOL CHOL BA BA FP FPH

Ca Mg Ca Mg AIN-93G AIN-93G Ca Mg 3 SD 4 9 14 23 28 Ca Mg Ca 9K(CBD9K) mrna Ca TRPV6 mrna Mg TRPM6 mrna Ca Ca Mg Mg Ca CBD9K mrna TRPV6 mrna TRPV6 mrna CBD9K mrna Mg Mg TRPM6 mrna TRPM6 mrna Ca Mg 1, 5) 2, 5) 3) 4) 1) ( ) 2) 3) 4) ( ) 5) 4, 5) TBT TBT Ca 2+ TBT TBT Ca 2+ 1. RCR-1 TBT 1 μm caspase-3 Propidium Iodide Ca 2+ TBT Ca 2+ Dulbecco s PBS (DPBS) BAPTA-AM 2. TBT Ca 2+ Ca 2+ Fura2-AM Ca 2+ calpain 3. JC-1 cytochrome c TBT RCR-1 caspase-3 Ca 2+ Ca 2+ calpain Ca 2+ BAPTA-AM Ca 2+ DPBS calpain cytochrome c TBT RCR-1 Ca 2+ 2

40 50 QOL PVEE PVEE HPLC Slc:ddY 9 OVX PVEE 20 mg/kg 8 Deoxyprydinoline DPD Tartarate Resistant Acid Phosphatase TRAP TRAP X CT TRAP mrna RT-PCR PVEE OVX TRAPmRNA DPD TRAP PVEE PVEE TRAP PVEE OVX PVEE 8 OVX PVEE PVEE 1) 2) 2) 2) 1) 2) ) Ca K Cu Mn Se medium chain fatty acids: MCT) Fe Zn Ca Cu BALB/C 40 1 10 C 3 1 50 100 150mL G-50 G-100 G-150 14 ICP-OES Fe Ca G-50 G-100 G-150

1) 1) 2) 1) 2) 1. 0.1mM NADH 2. NADPH NADPH 3. 0.1 0.5 mm 0.5 1 mm 2 mm 4. in vitro GSSG NADPH Ki 5 10 mm NAD(P)H

- 1) 1) 2) 1, 2) ArgRPseudomonas taetrolens NBRC 3460 D- 1) MALDI-TOF MS MALDI-TOF MS ArgR 2 A DTT B A B ArgR MALDI-TOF MS C47A/C73A-ArgR C47A/C73A-ArgR ArgR C47A/C73A-ArgR ArgR C47A/C73A-ArgR MALDI-TOF MS ArgR Cys47 Cys73 PLP ArgR ArgR 2 Cys Ala C47A/C73A-ArgR ArgR DTT Cys47-Cys73 ArgR ArgR Cys47-Cys73 ArgR 1) D. Matsui, T. Oikawa et al., (2009) Appl. Microbiol. Biotechnol., 83: 1045-1054. 1) 1) 2) 2) 1) 1) 2) K K1 K2 K3 4 K 4 SXR 4 K K1 K K K1 4 7 K K3 K K3 K K 58 mol/d K1 4 7 K3 (n = 4 5) 2 4 8 Sep-Pak Silica HPLC K K1 4 7 K1 7 2 4 K1 7 K3 4 K1 4 7 4 K 4 K3

- FAD FMN 2-2-CAA 2-2- 2-CAA 16S rrna 2-CAA 2-CAA 2-CAA Pseudomonas sp. YL 2-CAA 547 59,301 CAA67_YL CAA67_YL FAD 2-CAA H218O [18O] 2-CAA - 2--2-2- 2- FAD FADH2 CAA67_YL NAD(P)H AXXGXXG 205 211 NADH NADPH FAD NADH FAD CAA67_YL NADH FAD FADH2 2-1) 1) 1) 2) 2) 1) ( ) 2) 20 ppm 1 11 Wistar 220 g 2 1 1 4 2 2 1 mg /kg 0 4 3 9 Wistar 180 g 5 3 0 4 1 2 2 AUC 1 2 1 2 AUC

1) 2) 1) 2) (EPO) Biol Trace Elem Res 107: 289-292, 2005 HO-1 Sprague-Dawley 3 AIN-93G CONZn 4.5 mg/kg diet 4.5 ppm ZD Pair-Fed AIN-93G PF 3 10 4 HO-1 Ret Fisher PLSD 5 HO-1 CON ZD 3 Ret HO-1 CON ZD PF EPO EPO PF 21800073 Wistar 36 6 2 AIN93G 12.5 25 mg/kg 2 0.70 mg /ml 3.19 mg/ml 800 ml/kg 4 3 25 mg/kg 12.5 mg/kg 12.5 mg/kg

1, 4) 2) 3) 3) 4) 1) ( ) 2) 3) ( ) 4) TBT TBT 1. Wistar 6 170 g TBT 2.5 mg/kg body weight 24 96 CYH CYH 0.1 ppm 1 ppm 10 ppm 100 ppm TBT CYH 2. TBT 24 48 72 96 TBT GC/MS 3. Hematoxylin-Eosin HE TdT-mediated dutp-biotin Nick End Labeling (TUNEL) TBT CHY 100 96 0.1 10 ppm 50%GC/MS TBT TBT 24 TBT 24 96 TUNEL TBT 1) 2) 1) 1) 2) Rb Rb Rb Rb Rb Rb Rb Rb Rb 4 Wistar 62 8 Rb 0 4 8 25 50 100 200 1,000 ppm 46 Rb Williams 5% Rb Rb Rb 1 ppm Rb Rb 8 25 ppm 25 50 ppm 100 200 ppm Rb ppm Rb μg/g/ppm 0 4 6.6 4 8 7.8 8 25 4.4 25 50 10.7 50 100 12.9 100 200 7.8 200 1,000 6.1 Rb Rb 50 100 ppm Rb Rb50 100 ppm Rb50 100 ppm

4 26 1 50% 24 1 1 * 1) 2) 1) 1) 3) 1) 2) 3) 2000 1 400 μg 2006 2 5 45 33 7 29 400 μg/ 33 11 11 22 124 g 216 g 44.8% 41.4% 37.9% 27.6% 12 394 ± 113 μg 17 385 ± 103 μg 9 384 ± 120 μg 20 391 ± 102 μg 90% 400 μg 30%

1) 1) 2) 1) 2) 2010 50 μg/ 2 μg/ 5 μg/ 39 15 24 31.2 ± 4.0 FFQ L. plantarum ATCC 8014 50 100 50 4.5 N 4.5 N 100 μl 100 μl 37 18 610 nm 2001 2.5 ng/ml 2.9 ng/ml 2.8 ng/ml 2.3 ng/ml 18.8 μg/mgcre 24.3 μg/mgcre 13.2 μg/mgcre 14.6 μg/mgcre p < 0.05 36.5 μg 34.8 μg 35.2 μg 36.0 ± 7.2 μg/2010 1, 2) 1, 2) 2) 2) 1) 2) 75 10% 1) 60% 40% 2) (1) (1) Katayama M, Sugawa-Katayama,Y (2007) Effect of temperature on the diminution of retained arsenic in dried Hijiki, Sargassum fusiforme (harvey) Setchell, by water-soaking., J. Home Econ. Jpn, 58, 75-80. (2) Katayama M, Sugawa-Katayama Y, Yamaguchi Y, Murakami K, Hirata S (2008) Effect of temperature on the extraction of various arsenic compounds from dried Hijiki, Sargussum fusiforme by water-soaking as a pre-cooking process. Trace Nutrients Research 25: 134-138.

Se- GC-MS Se- - -Se- LC-MS g/g 125 45.685.2 0.1 g 0.1 ml 0.45 m LC-MS Applied Biosystems, API 3000 Cadenza CD-C18 Imtact/70/30 0 10/90 40 0.2 ml/min Inertsil ODS-3 GL Sciences /80/30 0 10/90 45 0.2 ml/min - -Se- LC-MS LC Se- - -Se- Se- - -Se- LC-MS 1) 2) 3) 4) 1) 1) 1) 2) 3) 4) 2 70 1998 1998 2008 10 2005 2 157 137 2005 77 78 NaKCa Mg P S ZnFe Cu Ca Na Zn Fe 40

1) 1) 2) 2) 3) 3) 1) 1, 2) 1) 1) 2) 3) 1, 2) 22.1 20 40 Klotho Klotho KO Klotho Klotho 500 g 550 g SD F 40 calorie restriction CR 2 1 4 Klotho real-time PCR Klotho SDS-PAGE F 511.4 ± 13.7 g 556.0 ± 15.5 g F 60 CR 529.3 ± 17.2 g 470.3 ± 9.8 g Real-time PCR Klotho m-rna F CR 1.5 SDS-PAGE Klotho F CR Klotho